SUPN EPS Estimates
Supernus Pharmaceuticals, Inc.
$40.18
-$1.83(-4.36%)
53
Overall
60
Value
40
Tech
60
Quality
Market Cap
$2.44B
Volume
810.41K
52W Range
$40.51 - $59.68
Target Price
$61.75
SUPN EPS estimates: the consensus estimate for Supernus Pharmaceuticals, Inc.'s current fiscal year is $1.97 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
SUPN EPS Estimates
- EPS estimate, current quarter
- $0.66
- EPS estimate, next quarter
- $0.75
- EPS estimate, current year
- $1.97
- EPS estimate, next year
- $3.86
- EPS growth, 3-year
- -100.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.68 |
| 2024 | $1.34 |
| 2023 | $0.02 |
| 2022 | $1.13 |
| 2021 | $1.01 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SUPN | $40.18 | -4.4% | 810.41K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Supernus Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW